Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.
Whatever the consensus opinion may be, our team at StockStory cuts through the noise by conducting independent analysis to determine a company’s long-term prospects. That said, here are three stocks where Wall Street’s pessimism is creating a buying opportunity.
Colgate-Palmolive (CL)
Consensus Price Target: $95.84 (7.9% implied return)
Formed after the 1928 combination between toothpaste maker Colgate and soap maker Palmolive-Peet, Colgate-Palmolive (NYSE: CL) is a consumer products company that focuses on personal, household, and pet products.
Why Is CL on Our Radar?
- Unparalleled brand awareness is evident in its $20.8 billion revenue base, which gives it advantageous terms because retailers must stock its products
- Differentiated product offerings are difficult to replicate at scale and lead to a best-in-class gross margin of 60.4%
- Strong free cash flow margin of 17.8% enables it to reinvest or return capital consistently
Colgate-Palmolive is trading at $88.80 per share, or 23.1x forward P/E. Is now the right time to buy? Find out in our full research report, it’s free.
FuelCell Energy (FCEL)
Consensus Price Target: $8.24 (-61% implied return)
Founded in 1969, FuelCell Energy (NASDAQ: FCEL) is a leading manufacturer and developer of carbonate fuel cell technology for stationary power generation.
Why Do We Love FCEL?
- Forecasted revenue growth of 11.6% for the next 12 months indicates its momentum over the last two years is sustainable
- Earnings growth has trumped its peers over the last two years as its EPS has compounded at 31.9% annually
- Negative free cash flow margin has improved over the last five years, showing the company is one step closer to financial self-sufficiency
FuelCell Energy’s stock price of $21.15 implies a valuation ratio of 5.1x forward price-to-sales. Is now a good time to buy? See for yourself in our full research report, it’s free.
Federated Hermes (FHI)
Consensus Price Target: $55.86 (0.5% implied return)
With roots dating back to 1955 and a pioneering role in money market funds, Federated Hermes (NYSE: FHI) is an investment management firm that offers a wide range of funds and strategies for institutional and individual investors.
Why Should You Buy FHI?
- Performance over the past two years was boosted by share buybacks, which enabled its earnings per share to grow faster than its revenue
- Stellar return on equity showcases management’s ability to surface highly profitable business ventures
At $55.56 per share, Federated Hermes trades at 10.9x forward P/E. Is now the time to initiate a position? Find out in our full research report, it’s free.
High-Quality Stocks for All Market Conditions
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.
